The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...

Lupin Ltd has received tentative approval from the FDA for its generic version of a combination HIV treatment.

Shares of Centene Corp. slid 5.45% to $61.29 Tuesday, on what proved to be an all-around positive trading session for the ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza, has ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they ...

IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World's Most Admired Companiestm ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...

Makers of drugs and medical devices say the tariffs on goods from Canada, Mexico and China could have an outsized impact on ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...

JB Pharma on Tuesday reported a 22% year-on-year (Y-o-Y) jump in net profit to Rs 162 crore for the quarter ended December 31 ...

The portfolio’s return was -3.87% (net) for the reporting period vs. MSCI World Index that returned -0.16% for the same ...